-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Clinical study of proton radiotherapy in urological cancers
[Japanese]. … Proton therapy for head and neck malignancies at
Tsukuba. … Cancer Journal 2006 Apr;12(2):155-9.
16630407 No malignancy
Makarova GV, Matveev BP, Leonova NS, … [Use of high energy protons
in the combination treatment of cervix neoplasms] [Russian]. … Uveal lymphoid neoplasia: a clinical-pathologic
correlation and review of the early form.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/L5UwXoftg4JHw4buVDhjUT
October 01, 2010 - tissue) tumors. … 25%
present as invasive tumors (12). … invasive
tumor (7). … Evidence on the natural
history of asymptomatic bladder cancer is lacking because
tumors are typically … tumor marker.
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V23%20Definitions%20Manual.pdf
August 01, 2006 - PROCS
172 172 DIGESTIVE MALIGNANCY
173 172 DIGESTIVE MALIGNANCY
174 174 G.I. … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS
204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205 DISORDERS … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
260 CDRG … PROCS EX MALIG
346 346 MALIGNANCY, MALE REPRO SYSTEM,
347 346 MALIGNANCY, MALE REPRO SYSTEM,
348
-
hcup-us.ahrq.gov/reports/natstats/his95/appaa.htm
September 01, 1998 - 20260 20261 20262 20263 20264 20265 20266 20267 20268
2340 2348 2349 7951
42 Secondary malignancies … 1975 1976 1977 1978 1980 1981 1982 1983 1984 1985 1986
1987 19881 19882 19889
43 Malignant … neoplasm without specification of site
1990 1991
44 Neoplasms of unspecified nature or uncertain … 2399
45 Maintenance chemotherapy, radiotherapy
V580 V581 V661 V662 V671 V672
46 Benign … benign neoplasm
V1272 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110
2111
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - (breast, colon,
lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology
for CINAHL, PsycINFO, EMBASE, and any other databases searched:
("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR
precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time
serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR
neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - early-stage cancers, the death rate from kidney cancer has
not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16-
18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … Given the increased incidence in early, low-stage tumors without improvement in cancer-related
deaths … Frank, I., et al., Independent validation of the 2002 American Joint Committee on cancer
primary tumor
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Weights%20Manual.pdf
January 06, 2025 - Procedure): CDRG 400 in MDC
17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated Neoplasms … MDC 17 – MYELOPROLIFERATIVE DISEASES AND DISORDERS AND POORLY DIFFERENTIATED
NEOPLASMS: The logic … Malignancy Codes: Diagnosis code V10.48 (history of malignancy, epididymis) is now
included as a history … of malignancy code within CDRG 465 (Aftercare With History of
Malignancy as Secondary Diagnosis). … MDC 17 (Myeloproliferative Diseases and Disorders and Poorly Differentiated
Neoplasms): CDRG 539 (Lymphoma
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - non-dermatologic malignancy (174,650 new cases) and the second
leading cause of cancer death (31,620 … With AS, tumors are not
immediately removed, irradiated, or ablated.3, 4 Instead, tumors are monitored … Stage 1
T2= tumor Stage 2
T3= tumor Stage 3
T4= tumor Stage 4
WMD= weighted mean differences
WW … / (121506)
2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514)
3 watchful … / (9241)
2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
April 01, 2006 - PROCS
172 172 DIGESTIVE MALIGNANCY
173 172 DIGESTIVE MALIGNANCY
174 174 G.I. … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS
204 … 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205 DISORDERS … 259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
260 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
261 261 … PROCS EX MALIG
346 346 MALIGNANCY, MALE REPRO SYSTEM,
347 346 MALIGNANCY, MALE REPRO SYSTEM,
348
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/MNPOAvideotranscript.pdf
September 24, 2010 - On the second hospital day, a progress note
documents the discovery of a malignant neoplasm of the lung … patient is
discharged with diagnoses of obstructive chronic bronchitis with acute
exacerbation and malignant … neoplasm of the lower lobe of the lung.
… on screen: Coding Study #2 – POA Coding
Michael speaking:
Final coded diagnoses include lung cancer … Both could have been coded as present on admission
because cancer is a chronic diagnosis and the exacerbation
-
hcup-us.ahrq.gov/reports/statbriefs/sb37.pdf
September 01, 2007 - http://plan2004.cancer.gov/public/survivor.htm
4The term “brain tumors” refers to all cancers of the … Characteristics of two common pediatric cancers: leukemias and brain tumors
Table 3 provides detailed … Among children and adolescents, the most common
cancer stays were for leukemias and brain tumors. … primary 3,000 11.6 $33,900 $102.6 million 4.2 47.7% 10.3% *
Secondary malignancies 2,200 7.2 … Note: Miscellaneous cancers that are grouped as “other benign neoplasms” (CCS category 47) are excluded
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-ChangeLog-v20212-v20221.xlsx
October 01, 2021 - and unspecified infections INF009 Parasitic, other specified and unspecified infections
C563 Malignant … neoplasm of bilateral ovaries NEO033 Female reproductive system cancers - ovary NEO033 Female reproductive … system cancers - ovary NEO033 Female reproductive system cancers - ovary
C7963 Secondary malignant … neoplasm of bilateral ovaries NEO070 Secondary malignancies NEO070 Secondary malignancies NEO070 Secondary … malignancies
C847A Anaplastic large cell lymphoma, ALK-negative, breast NEO058 Non-Hodgkin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - Cancers of the skin are the most common forms of cancer. … are
associated with other malignancies (including hematologic and respiratory tract cancers).3 In … The rationale for this is
the growing recognition of skin cancer as a leading form of second malignancy … Association of nonmelanoma skin
cancer with second malignancy. Cancer
2004;100(1):130-138.
4. … Search Strategies
# Search Terms
1 exp Skin Neoplasms/
2 exp "Neoplasms, Adnexal and Skin Appendage
-
hcup-us.ahrq.gov/reports/statbriefs/sb37.jsp
September 01, 2007 - Characteristics of two common pediatric cancers: leukemias and brain tumors
Table 3 provides detailed … While leukemias and brain tumors required the most hospital stays in children, hospitalizations for cancers … of cancer or secondary cancer)
– 43: Cancer without specification of site
– 44: Tumors of unspecified … http://plan.cancer.gov/.
4 The term "brain tumors" refers to all cancers of the brain and nervous system … Note: Miscellaneous cancers that are grouped as "other benign neoplasms" (CCS category 47) are excluded
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - cell lung cancer (SCLC)
comprises approximately 15% of all lung cancers.2 The five-year survival rate … Lung cancers are classified based on the size
of the main tumor, whether it has locally invaded other … '/de OR cancer OR tumor* OR tumour* OR mass* OR
neoplasm* AND (stage OR 'staging'/de OR staging OR class … OR tumor* OR tumour* OR mass* OR neoplasm*) AND
(stage OR staging OR class*)
Source: www.effectivehealthcare.ahrq.gov … [tiab] OR neoplasm[tiab] OR tumor*[tiab] OR
tumour*[tiab]) AND (care[tiab] OR treatment[tiab] OR
therapy
-
hcup-us.ahrq.gov/reports/statbriefs/sb232-Hepatitis-C-Hospital-Stays-Trends.pdf
June 19, 2017 - develop a chronic infection that can result
in cirrhosis, liver failure, hepatocellular carcinoma (liver cancer … Liver cancer was
most common among hepatitis C-plus stays at 7.7 percent. … 155.0 Malignant neoplasm of liver, primary
155.1 Malignant neoplasm of intrahepatic bile ducts
155.2 … Malignant neoplasm of liver, not specified as primary or secondary
197.7 Liver, specified as secondary … malignant neoplasm
230.8 Carcinoma in situ of liver and biliary system
235.3 Neoplasm of uncertain
-
hcup-us.ahrq.gov/reports/statbriefs/sb232-Hepatitis-C-Hospital-Stays-Trends.jsp
December 01, 2017 - Liver cancer was most common among hepatitis C-plus stays at 7.7 percent. … 155.0
Malignant neoplasm of liver, primary
155.1
Malignant neoplasm of intrahepatic bile … ducts
155.2
Malignant neoplasm of liver, not specified as primary or secondary
197.7 … Liver, specified as secondary malignant neoplasm
230.8
Carcinoma in situ of liver and biliary … system
235.3
Neoplasm of uncertain behavior, liver and biliary passages
Cirrhosis of the
-
hcup-us.ahrq.gov/reports/natstats/commdx/table1j.htm
February 11, 2011 - Cancer of bladder [32] 10,019 18.79 0.03 … Cancer of pancreas [17] 2,706 5.14 0.01 … Secondary malignancies [42] 1,311 2.60 0.00 … Secondary malignancies [42] 10,713 21.70 0.03 … Other and unspecified benign neoplasm [47] 11,443 23.96 0.03
-
hcup-us.ahrq.gov/reports/natstats/his96/clinclas.htm
September 01, 1999 - How do the average mean charges for alternative treatments of benign
uterine cancer compare? … ventricular fibrillation with mortality rates of 50 percent,
followed by shock (49.8 percent) and malignant … neoplasm without specification
of site (29.6 percent). … fibrillation (category 7.2.10), with a
mortality rate of 50.0 percent; shock (17.1.5), 49.8 percent; and malignant … neoplasm without specification of site (2.13), 29.6 percent.
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
June 01, 2009 - 055 054 NERVOUS SYSTEM NEOPLASMS
056 056 DEG NERVOUS SYSTEM … 181 180 RESP NEOPLASMS
182 180 RESP NEOPLASMS … 375 374 DIGESTIVE MALIGNANCY
376 374 DIGESTIVE MALIGNANCY … 657 656 KIDNEY&URETER PX/NEOPLASM
658 656 KIDNEY&URETER PX/NEOPLASM … 659 659 KIDNEY&URETER PX/NON-NEOPLASM
660 659 KIDNEY&URETER PX/NON-NEOPLASM